During the past decade, Heart Care Associates, P.C. conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 4 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Heart Care Associates, P.C." #1 collaborator was "Duke Clinical Research Institute" with 1 trials as a collaborator and "Pfizer" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Heart Care Associates, P.C." are "Cardiovascular Disease" (2 trials), "Acute Coronary Syndrome" (1 trials), "Atherosclerotic Cardiovascular Disease" (1 trials) and "Hyperlipidemia" (1 trials). Many other conditions were trialed in "Heart Care Associates, P.C." in a lesser frequency.

Most popular intervention types in "Heart Care Associates, P.C." are "Drug" (4 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "bococizumab (PF-04950615)" (2 trials), "Apixaban" (1 trials), "Bococizumab 150mg" (1 trials) and "Bococizumab 150mg placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Heart Care Associates, P.C." are 5 trials for "All" genders.

Currently, there are NaN active trials in "Heart Care Associates, P.C.". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Heart Care Associates, P.C., undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Heart Care Associates, P.C., 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".